Zilretta™ (triamcinolone acetonide) – New drug approval
October 6, 2017 – Flexion Therapeutics announced the FDA approval of Zilretta (triamcinolone acetonide) extended-release injection, for the management of osteoarthritis (OA) pain of the knee.
Download PDF
